Abbott Laboratories (ABT) Non-Current Deferred Tax Liability (2010 - 2014)

Abbott Laboratories' Non-Current Deferred Tax Liability history runs 5 years deep, the most recent figure standing at $860.0 million for Q4 2014.

• In Q4 2014, Non-Current Deferred Tax Liability rose 84.55% year-over-year to $860.0 million; the TTM figure through Dec 2014 stood at $860.0 million (up 84.55% YoY), while the FY2014 annual figure was $860.0 million, up 84.55% from the prior year.
• Non-Current Deferred Tax Liability came in at $860.0 million for Q4 2014 at Abbott Laboratories, up from $466.0 million in the prior quarter.
• In the past five years, Non-Current Deferred Tax Liability ranged from a high of $1.1 billion in Q4 2010 to a low of $466.0 million in Q4 2013.
• A 5-year average of $770.2 million and a median of $710.0 million in 2012 frame the typical range for Non-Current Deferred Tax Liability.
• Across the five-year window, Non-Current Deferred Tax Liability sank 36.78% in 2011 and surged 84.55% in 2014, its largest moves.
• Abbott Laboratories' Non-Current Deferred Tax Liability stood at $1.1 billion in 2010, then tumbled by 36.78% to $703.0 million in 2011, then increased by 1.0% to $710.0 million in 2012, then tumbled by 34.37% to $466.0 million in 2013, then soared by 84.55% to $860.0 million in 2014.
• According to Business Quant data, Non-Current Deferred Tax Liability over the past three periods registered $860.0 million, $466.0 million, and $710.0 million for Q4 2014, Q4 2013, and Q4 2012 respectively.

Peer Comparison